Microvision, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
MicroVision is holding its 2026 Annual Meeting of Shareholders to vote on key proposals, including a reverse stock split and the issuance of shares for convertible notes, aimed at improving stock price and financial flexibility.
NASDAQ
MicroVision, Inc. has filed a supplement to its proxy statement to inform shareholders of the merger between its independent auditor, Moss Adams LLP, and Baker Tilly US, LLP, resulting in Baker Tilly's appointment as the new auditor.
NASDAQ
MicroVision, Inc. is strongly urging shareholders to vote 'FOR' Proposal Two, which seeks to increase the number of authorized shares of common stock, emphasizing its critical importance for executing the company's strategic plan and demonstrating financial strength.
NASDAQ
MicroVision is asking shareholders to approve an increase in authorized shares of common stock and an amendment to the 2022 Equity Incentive Plan at the upcoming annual meeting.
NASDAQ
MicroVision's 2024 Annual Meeting of Shareholders will be held virtually on June 5, 2024, to vote on director elections, executive compensation, and the ratification of the company's accounting firm.